Oncolytics BiotechONCY
13F holders, Q1 2024 (March 31)36holders
2famous investors
$1.06avg. 13F price*
At the end of Q1 2024, 36 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings. The largest holders were Morgan Stanley ($369K), International Assets Investment Management, LLC ($214K) and Citadel Advisors ($173K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Oncolytics Biotech Inc.
- CUSIP
- 682310875
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $179K |
| Exits | 14 | $5.4M |
Ownership 36 holders
| Morgan Stanley | 0.00% | Add +50.5% | 348,313 | $369K |
| International Assets Investment Management, LLC | 0.02% | Add +0.8% | 201,452 | $214K |
| Citadel Advisors | 0.00% | Add +42.9% | 162,765 | $173K |
| Goldman Sachs Group Inc. | 0.00% | New | 83,598 | $89K |
| Commonwealth Equity Services, LLC | 0.00% | Add +12.9% | 62,764 | $67K |
| Royal Bank of Canada | 0.00% | Add +11.1% | 61,033 | $65K |
| Cibc World Market Inc. | 0.00% | Reduce -4.5% | 58,150 | $62K |
| Virtu Financial LLC | 0.00% | New | 51,889 | $55K |
| Geode Capital Management, LLC | 0.00% | No change | 41,942 | $44K |
| Millennium Management | 0.00% | Reduce -68.0% | 40,887 | $43K |
| Long Focus Capital Management, LLC | 0.00% | No change | 40,000 | $42K |
| Bank of Montreal | 0.00% | Reduce -0.7% | 37,320 | $39K |
| Ausdal Financial Partners, Inc. | 0.00% | Reduce -13.3% | 26,000 | $28K |
| Brave Asset Management Inc. | 0.01% | No change | 25,000 | $27K |
| LPL Financial LLC | 0.00% | Reduce -8.0% | 18,009 | $19K |
| Headinvest, LLC | 0.00% | Add +43.4% | 16,534 | $18K |
| C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 0.00% | No change | 15,000 | $16K |
| Osaic Holdings, Inc. | 0.00% | Add +44.8% | 13,339 | $14K |
| National Bank of Canada | 0.00% | Add +212.8% | 11,697 | $13K |
| Banque Cantonale Vaudoise | 0.00% | No change | 11,900 | $13K |
| Two Sigma Securities, LLC | 0.00% | Reduce -49.5% | 11,816 | $13K |
| JPMorgan Chase & Co. | 0.00% | No change | 11,500 | $12K |
| Kingsview Wealth Management, LLC | 0.00% | No change | 11,000 | $12K |
| PFG Investments, LLC | 0.00% | New | 10,500 | $11K |
| Professional Advisory Services Inc. | 0.00% | New | 10,000 | $11K |
| Atom Investors LP | 0.00% | New | 10,257 | $11K |
| Cedar Mountain Advisors, LLC | 0.00% | No change | 5,651 | $6K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,294 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -5.6% | 4,401 | $5K |
| IFP Advisors, Inc | 0.00% | New | 2,500 | $3K |
| Cwm, LLC | 0.00% | No change | 2,325 | $2K |
| UBS Group AG | 0.00% | Reduce -75.2% | 1,164 | $1K |
| JNBA Financial Advisors | 0.00% | No change | 210 | $223 |
| Credential Qtrade Securities Inc. | 0.00% | New | 52 | $55 |
| Wolff Wiese Magana LLC | 0.00% | No change | 31 | $33 |
| 1832 Asset Management L.P. | 0.00% | No change | 5 | $5 |
"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.